Carmustine

Back to search

Molecule Structure

Scientific Name

Carmustine

Description of the Drug

Carmustine is an alkylating agent used in the treatment of various malignancies, including brain tumours and multiple myeloma, among others.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00262

Brand Name(s)

Bicnu, Gliadel

Company Owner(s)

Ingenus Pharmaceuticals Llc, Avet Lifesciences Ltd, Navinta Llc, Accord Healthcare Inc, Sti Pharma Llc, Meitheal Pharmaceuticals Inc, Dr Reddys Laboratories Ltd, Amneal Eu Ltd, Jiangsu Hengrui Pharmaceuticals Co Ltd, Azurity Pharmaceuticals Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
DNA NUCLEIC-ACID INHIBITOR CHEMBL2311221
RNA NUCLEIC-ACID INHIBITOR CHEMBL2311222
Glutathione reductase SINGLE PROTEIN INHIBITOR CHEMBL2755

Unichem Links

SureChEMBL SCHEMBL4503
PharmGKB PA448810
Human Metabolome Database HMDB0014407
DrugBank DB00262
PubChem: Thomson Pharma 15171986
PubChem 2578
Mcule MCULE-3131772074
LINCS LSM-6584
Nikkaji J2.968H
BindingDB 50015950
EPA CompTox Dashboard DTXSID8022743
DrugCentral 512
Brenda 144149 9584 56876 127601 18214 19848 4461
ChemicalBook CB0449612
Guide to Pharmacology 6800
rxnorm CARMUSTINE GLIADEL BICNU
KEGG Ligand C06873
ChEBI 3423
ZINC ZINC000003830387